ConductScience.org, home

Paper34873458

Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer.

Yousafzai NA and 3 others. Am J Cancer Res, 2021. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer. Papers, record 34873458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34873458

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer.
PubMed
Journal
Am J Cancer Res
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
3.78
iCite
Revised in PubMed
2021-12-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yousafzai NANeelum Aziz
2Jin HHongchuan
3Ullah MMujib
4Wang XXian

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References136

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128689995SIRT1 Enhances the Survival of Human Embryonic Stem Cells by Promoting DNA Repair.Stem Cell Reports2017https://conductscience.org/library/papers/28689995PubMed
231043584SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer.Cell Death Dis2019https://conductscience.org/library/papers/31043584PubMed
317694089Sirtuins: critical regulators at the crossroads between cancer and aging.Oncogene2007https://conductscience.org/library/papers/17694089PubMed
431258843An emerging role of CD9 in stemness and chemoresistance.Oncotarget2019https://conductscience.org/library/papers/31258843PubMed
518046409Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.Nature2007https://conductscience.org/library/papers/18046409PubMed
615902208An inhibitor of Bcl-2 family proteins induces regression of solid tumours.Nature2005https://conductscience.org/library/papers/15902208PubMed
731704472Emerging role of stem cell-derived extracellular microRNAs in age-associated human diseases and in different therapies of longevity.Ageing Res Rev2020https://conductscience.org/library/papers/31704472PubMed
817234790Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.Cancer Res2007https://conductscience.org/library/papers/17234790PubMed
928166203LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.Oncogene2017https://conductscience.org/library/papers/28166203PubMed
1029890735Resveratrol Ameliorates Microcystin-LR-Induced Testis Germ Cell Apoptosis in Rats via SIRT1 Signaling Pathway Activation.Toxins (Basel)2018https://conductscience.org/library/papers/29890735PubMed
1120007699BCR-ABL gene expression is required for its mutations in a novel KCL-22 cell culture model for acquired resistance of chronic myelogenous leukemia.J Biol Chem2010https://conductscience.org/library/papers/20007699PubMed
1216892051Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.Nat Cell Biol2006https://conductscience.org/library/papers/16892051PubMed
1325884180Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.BMC Cancer2015https://conductscience.org/library/papers/25884180PubMed
1430273928
KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in T-Cell Acute Lymphoblastic Leukemia (T-ALL) [corrected].
Cell Physiol Biochem2018https://conductscience.org/library/papers/30273928PubMed
1530327428Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage.J Biol Chem2018https://conductscience.org/library/papers/30327428PubMed
1621062352Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model.J Pineal Res2011https://conductscience.org/library/papers/21062352PubMed
1721078544Targeting apoptosis pathways in pancreatic cancer.Cancer Lett2013https://conductscience.org/library/papers/21078544PubMed
1817151364Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.N Engl J Med2006https://conductscience.org/library/papers/17151364PubMed
1921508974An analogy between the evolution of drug resistance in bacterial communities and malignant tissues.Nat Rev Cancer2011https://conductscience.org/library/papers/21508974PubMed
2014976264Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.Science2004https://conductscience.org/library/papers/14976264PubMed

See all 136 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42958661Xiaoyao San enhances the sensitivity of hepatocellular carcinoma to 5-fluorouracilautophagy modulation.J Tradit Chin Med2026https://conductscience.org/library/papers/42958661PubMed
42848173Arbutin as a promising cardioprotective anticancer adjuvant with doxorubicin in solid Ehrlich carcinoma through targeting NEK7-dependent inflammasome/SIRT1/caspase-3/oxidative stress pathways.Mol Cell Biochem2026https://conductscience.org/library/papers/42848173PubMed
42738658Antileukemic Activity of Sechium Hybrid H387 Extract Associated with SIRT1 Downregulation and p53 Acetylation in Human Chronic Myeloid Leukemia Cells.Molecules2026https://conductscience.org/library/papers/42738658PubMed
42511457Immunological Microenvironment Diversity in Homogeneous and Non-Homogeneous Oral Leukoplakia.Int J Mol Sci2026https://conductscience.org/library/papers/42511457PubMed
41304967Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304967PubMed
40944749Non-coding RNAs' pivotal importance in modulation of cancer sensitivity to Topotecan: a systematic review.Med Oncol2025https://conductscience.org/library/papers/40944749PubMed
40806596Sodium Caseinate Induces Apoptosis in Cytarabine-Resistant AML by Modulating SIRT1 and Chemoresistance Genes, Alone or in Combination with Cytarabine or Daunorubicin.Int J Mol Sci2025https://conductscience.org/library/papers/40806596PubMed
40591009SIRT1 as a masterful reciprocal regulator of molecular mechanisms and signaling pathways involved in tumor growth and expansion.Clin Exp Med2025https://conductscience.org/library/papers/40591009PubMed
40538510Targeting the NAD+/SIRT1 axis: A metabolic strategy to overcome oxaliplatin resistance in colorectal cancer.World J Gastroenterol2025https://conductscience.org/library/papers/40538510PubMed
40517236Bypassing the guardian: regulated cell death pathways in p53-mutant cancers.Cell Mol Biol Lett2025https://conductscience.org/library/papers/40517236PubMed
40027307Global requirements for manufacturing and validation of clinical grade extracellular vesicles.J Liq Biopsy2024https://conductscience.org/library/papers/40027307PubMed
39766219Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD+/SIRT1 Pathway.Biomolecules2024https://conductscience.org/library/papers/39766219PubMed
39403142The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy.Front Pharmacol2024https://conductscience.org/library/papers/39403142PubMed
39266959SIRT1-mediated deacetylation of FOXO3 enhances mitophagy and drives hormone resistance in endometrial cancer.Mol Med2024https://conductscience.org/library/papers/39266959PubMed
38865161Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma.Cancer Biol Ther2024https://conductscience.org/library/papers/38865161PubMed
38567911Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells.Elife2024https://conductscience.org/library/papers/38567911PubMed
38473244Advances in 3D Culture Models to Study Exosomes in Triple-Negative Breast Cancer.Cancers (Basel)2024https://conductscience.org/library/papers/38473244PubMed
38369747Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors.Epigenetics2024https://conductscience.org/library/papers/38369747PubMed
38322669The Implication of Growth Arrest-Specific 5 rs145204276 Polymorphism and Serum Expression of Sirtuin 1, Transforming Growth Factor-Beta, and microRNA-182 in Breast Cancer.Clin Med Insights Oncol2024https://conductscience.org/library/papers/38322669PubMed
38067304Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review.Cancers (Basel)2023https://conductscience.org/library/papers/38067304PubMed

See all 39 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SIRT123411PubTator's text mininghttps://conductscience.org/library/genes/23411

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34873458

GET https://conductscience.org/api/papers/v1/34873458/references?page=2